William Blair initiates AST Spacemobile stock with Market Perform rating

Published 21/08/2025, 11:06
William Blair initiates AST Spacemobile stock with Market Perform rating

Investing.com - William Blair initiated coverage on AST Spacemobile (NASDAQ:ASTS), now valued at $16.04 billion, with a Market Perform rating on Thursday.

The research firm noted that AST Spacemobile shares have appreciated by more than 1,600% since May 2024, significantly outperforming the S&P 500’s 25% increase during the same period.

William Blair pointed out that AST shares currently trade at 31 times their 2030 revenue estimate, suggesting a high valuation relative to future earnings potential.

The firm identified several risk factors for AST Spacemobile, including intense competition from SpaceX, potential launch delays, and questions about the true size of the total addressable market (TAM).

William Blair concluded that these risks will likely result in AST Spacemobile shares being range-bound, supporting their Market Perform rating despite investor interest in SpaceX alternatives.

In other recent news, AST SpaceMobile announced its second-quarter 2025 earnings, revealing a notable revenue shortfall. The company’s earnings per share (EPS) were reported at -$0.41, significantly lower than the anticipated -$0.21, representing a 95.24% negative surprise. Revenue figures were also disappointing, coming in at $1.15 million, which was a 79.32% miss compared to the expected $5.56 million. These financial results highlight challenges the company is facing in meeting market expectations. Despite the earnings miss, there have been no recent updates regarding mergers or acquisitions involving AST SpaceMobile. Analysts have not recently upgraded or downgraded the company’s stock, leaving its current rating unchanged. Investors will likely be watching closely for any future announcements or strategic changes that could impact the company’s performance. These developments underscore the importance of closely monitoring AST SpaceMobile’s financial health and strategic direction.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.